Drug intelligence / Profile preview

compound aminobutyric acid and vitamin e

Development stage
Unknown
Lead developer
Guangzhou Baiyunshan Pharmaceutical Holdings
Modality
Small Molecules
Administration
Oral
01

Overview

Compound Aminobutyric Acid Vitamin E Capsule (marketed under the brand name Baitai) is an approved oral combination therapy developed by Guangzhou Baiyunshan Pharmaceutical Group for the treatment of various neurological disorders. The formulation contains a complex mixture of synthetic compounds—including γ-aminobutyric acid (GABA), vitamin E, choline chloride, oryzanol, vitamin B1, and niacin—alongside several traditional Chinese medicinal extracts such as Panax notoginseng, Salvia miltiorrhiza, Acanthopanax, Polygonum multiflorum, and Acorus gramineus. It is primarily indicated for cerebral arteriosclerosis, the sequelae of stroke or brain trauma, and general decline in cerebral function. The drug exerts its therapeutic effects through multiple mechanisms, including neurotransmitter modulation via the GABAergic system, antioxidant protection against oxidative stress, and improvement of cerebral metabolism and blood flow.

Brand names
Baitai百泰
Other names
Compound Aminobutyric Acid Vitamin E Capsule复方氨基丁酸维E胶囊
02

Targets

GABRR (GABA-A receptor subunit rho)

Beyond the preview

Go deeper on compound aminobutyric acid and vitamin e.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on compound aminobutyric acid and vitamin e.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call